## Abstract BRL 26850A has been extensively reported ^1^ as a novel β‐adrenoceptor agonist. In order to perform metabolism studies, carbon‐14 radiolabelled BRL 26830A was synthesised from potassium [^14^C]cyanide. As BRL 26830A contains two asymmetric centres, the initial product required resolutio
14C-labeling of a novel atypical β-adrenoceptor agonist, SM-11044
✍ Scribed by Motohiro Kurosawa; Hiroshi Kanamaru; Kazuhiko Nishioka
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 637 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
2S,3R)-2-[3-(4-Fluorophenyl)]propylamino-3-(3,4-di hydroxyphenyl)-3-hydroxypropionic acid pyrrolidine amide hydrobromide (SM-11044) was labeled with carbon-14 for use in mammalian metabolic studies. The synthesis was achieved according to the scheme shown in Fig. 5. Grignard reaction of 3,4-methylenedioxyphenylmagnesium bromide with ["Clcarbon dioxide liberated from barium ("Clcarbonate (6) gave the acid (5). Reduction of 5 with lithium aluminum hydride followed by oxidation of the resulting benzyl alcohol (11) with chromium oxide-pyridine complex afforded the aldehyde (a). Condensation of 9 with the optically active (0oxazolidinone (m yielded the alcohol (w. Catalytic hydrogenation of 12 and subsequent hydrolysis produced the optically active p-hydroxyaamino acid (2), which was treated with N-carbomethoxyphthalimide to give the hydroxy acid (la).
Reaction of J3 with pivaloyl chloride gave the corresponding mixed anhydride, which was allowed to react with pyrrolidine to provide the amide (M). Deprotection of 14 with hydrazine hydrate afforded the hydroxyamide (E). Condensation of I5 with the aldehyde (Ls) and subsequent reduction of the resulting imine with sodium cyanoborohydride produced the fluoride (Iz). Cleavage of the methylenedioxy group of Lz gave the free base of 1 , which was treated with hydrobromic acid to afford 1. The overall yield was 11.1%from6.
📜 SIMILAR VOLUMES
## Abstract Two ^14^C‐labelled versions of AJ‐9677, a novel anti‐diabetic drug candidate, have been synthesized. The first, [acetic acid‐2‐^14^C]AJ‐9677, was synthesized via a four‐step process starting from 2‐chloro‐__N,N__‐diethyl[2‐^14^C]acetamide (**3**), and the second, [hydroxymethine‐^14^C]A
## Abstract (1__R__,5__S__,6__S__)‐2‐ [(3__S__,5__S__)‐5‐Dimethylaminocarbonylpyrrolidin‐3‐ylthio]‐6‐ [(1__R__)‐1‐hydroxyethyl]‐1‐methylcarbapen‐2‐em‐3‐carboxylic acid trihydrate (SM‐7338), a novel 1 β‐methyl carbapenem antibiotic, was labeled with carbon‐14 at the C3 position of the carbapenem nuc
## SUM MARY A ''C-labelled form of 2-chloro-K[(R)-(2-benzoxazolyl)thio-2-propyl]adenosine a, a novel antiischaemic adenosine A, agonist, has been prepared in three steps from [8- '4C]-9-(2,3,5-tri-0-benzoyl-~-D-ribofuranosyl)-2,6-dichloropurine a. The overall radiochemical yield was 56%. The radio